Post-translational modifications of histones play an important
role in regulating
chromatin dynamics and function. One of the
modifications,
methylation, occurs on both lysine and arginine
residues, and
methylation status defines the epigenetic program
of a
cell by determining
chromatin structure and thereby regulating
DNA-dependent processes such as
transcription. Until recently,
histone
methylation was considered to be irreversible. However,
the discovery of histone demethylases revealed that histone
methylation is more dynamic than previously recognized. This
protocol describes two different
in vitro histone demethylase
enzyme reactions and three different methods for measuring histone
demethylase activity. The first reaction (type I) uses the Fe(II)-
and

-ketoglutarate-dependent dioxygenase family of histone demethylase
(represented by JmjC domain-containing histone demethylase [JHDM]);
the second (type II) is for the flavin adenine dinucleotide
(FAD)-dependent amine oxidase family (represented by lysine-specific
demethylase 1 [LSD1]). Histone demethylase activity can then
be detected by measuring the release of radiolabeled formaldehyde
from
3H-labeled methylated histone
substrates, by monitoring
the change in
methylation levels of histone
substrates by immunoblotting
with site-specific methylhistone
antibodies, or by using mass
spectrometry to detect reductions in histone
peptide masses
that correspond to methyl groups. These
assays can be applied
to a wide range of histone demethylase studies, including the
measurement of histone demethylase activity in
tissue and
cell lysates, identification of novel histone demethylases, and
screening for
inhibitors of histone demethylases.